VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
BLCO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
BLCOBausch + Lomb Corporation
$17.11$6.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBLCOBalance Sheet

Bausch + Lomb Corporation (BLCO) Balance Sheet

7Y historyFree accessUpdated daily

Total debt plummeted from $5.1B to $43M in 2026Q2, driving D/E to 0.01, while retained earnings deficit widened to -$1.0B and goodwill of $4.7B (34% of assets) remains an impairment risk.

Income StatementBalance SheetCash FlowRatios

BLCO Balance Sheet

Annual statement

BLCO Balance Sheet

Bausch + Lomb Corporation (BLCO) balance sheet — 7-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets2.92B2.98B2.79B2.74B2.14B1.64B1.65B1.7B
Cash & Short-Term Investments367M383M305M334M380M174M238M192M
Cash Only367M383M305M334M380M174M238M192M
Short-Term Investments00000000
Accounts Receivable1.16B1.22B1.03B875M726M721M645M713M
Days Sales Outstanding78.5987.3778.1777.0370.3369.96968.88
Inventory999M976M1.04B1.03B628M572M616M592M
Days Inventory Outstanding158.71154.35202228.51150.9142.32174.97162.83
Other Current Assets396M397M421M505M403M3M155M198M
Total Non-Current Assets10.94B11.04B10.68B10.7B9.01B9.19B9.61B9.77B
Property, Plant & Equipment1.8B1.76B1.49B1.5B1.42B1.23B1.26B1.09B
Fixed Asset Turnover3.01x2.90x3.23x2.76x2.66x3.07x2.70x3.47x
Goodwill4.72B4.76B4.52B4.58B4.51B4.59B4.68B4.55B
Intangible Assets3.17B3.28B3.49B3.59B2.06B2.26B2.56B2.85B
Long-Term Investments7M7M19M19M12M000
Other Non-Current Assets294M303M275M92M84M180M65M82M
Total Assets13.86B14.02B13.47B13.44B11.14B10.82B11.27B11.47B
Asset Turnover0.38x0.36x0.36x0.31x0.34x0.35x0.30x0.33x
Asset Growth %9.27%4.11%0.2%20.62%2.97%-3.93%-1.76%-
Total Current Liabilities1.89B1.92B1.74B1.58B1.3B1.1B909M1.03B
Accounts Payable426M388M389M522M317M239M178M262M
Days Payables Outstanding64.8261.3675.85116.0476.1759.4650.5672.06
Short-Term Debt43M77M40M57M51M28M18M16M
Deferred Revenue (Current)00000000
Other Current Liabilities1.42B1.46B459M709M732M356M544M573M
Current Ratio1.55x1.55x1.60x1.74x1.65x1.49x1.82x1.64x
Quick Ratio1.02x1.04x1.01x1.09x1.16x0.97x1.14x1.07x
Cash Conversion Cycle172.49180.36204.32189.51145.06152.75193.41159.65
Total Non-Current Liabilities5.53B5.58B5.19B4.94B2.75B322M369M401M
Long-Term Debt05.17B4.74B4.53B2.41B000
Capital Lease Obligations125M125M120M87M92M92M83M77M
Deferred Tax Liabilities70M19M13M14M7M000
Other Non-Current Liabilities5.51B271M310M310M237M230M286M324M
Total Liabilities7.42B7.5B6.92B6.52B4.04B1.42B1.28B1.44B
Total Debt43M5.37B4.94B4.68B2.55B140M101M93M
Net Debt-324M4.99B4.63B4.34B2.17B-34M-137M-99M
Debt / Equity0.01x0.82x0.75x0.68x0.36x0.01x0.01x0.01x
Debt / EBITDA0.05x8.82x8.25x9.13x4.36x0.19x0.14x0.11x
Net Debt / EBITDA-0.41x8.19x7.74x8.48x3.71x-0.05x-0.20x-0.11x
Interest Coverage0.84x0.26x0.41x0.41x1.50x---
Total Equity6.44B6.52B6.54B6.92B7.1B9.4B9.99B10.03B
Equity Growth %-3.49%-0.38%-5.43%-2.55%-24.47%-5.87%-0.44%-
Book Value per Share18.0518.4318.6019.7420.2926.8628.5428.66
Total Shareholders' Equity6.38B6.45B6.47B6.85B7.03B9.33B9.92B9.96B
Common Stock0000010.36B10.81B11.01B
Retained Earnings-1.02B-931M-571M-254M6M000
Treasury Stock00000000
Accumulated OCI-1.22B-1.18B-1.39B-1.25B-1.26B-1.03B-889M-1.05B
Minority Interest68M71M71M70M68M73M70M73M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Goodwill impairment risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Stability Amidst Growth

Total assets grew from $13.3B in 2024Q1 to $13.9B in 2026Q2, while equity remained near $6.4B, indicating a stable balance sheet despite revenue acceleration, per reported figures.

The balance sheet has remained remarkably stable over the past ten quarters, with total assets hovering around $13.5B and equity consistently near $6.4B. This stability, despite revenue growth of 8.7% year-over-year in 2026Q2, suggests that the company is funding its expansion without significant balance sheet expansion, possibly through operational cash flow. The slight increase in assets is driven by growth in PPE and intangibles, but the overall leverage has not increased, indicating a disciplined approach to capital deployment.

Leverage Drops Sharply in 2026Q2

Total debt plummeted from $5.1B in 2026Q1 to $43M in 2026Q2, driving D/E from 0.79 to 0.01, as per the latest balance sheet, suggesting a major debt repayment or restructuring.

The dramatic reduction in total debt in 2026Q2 is a significant event, as D/E fell from 0.79 to 0.01. This appears to be a strategic deleveraging, possibly through a debt repayment or refinancing, which substantially reduces interest expense and refinancing risk. However, the suddenness warrants investigation into the source of funds, as cash only increased by $99M, implying the repayment may have been funded by other means, such as asset sales or equity issuance, which could have implications for equity quality.

Asset Mix Reflects Acquisition-Driven Growth

Goodwill and intangibles constitute approximately 34% of total assets at $4.7B, with PPE growing steadily to $1.8B, as reported in financial statements, indicating a mix of acquisition-led and organic investment.

The asset base is heavily weighted towards goodwill and intangibles, which have remained stable around $4.7B, suggesting that past acquisitions have not been impaired but also that the company's growth is partly dependent on acquired assets. PPE has grown from $1.4B to $1.8B over the period, indicating ongoing investment in fixed assets, which aligns with the moderate capex intensity noted in cash flow analysis. The stability of goodwill is a positive sign, but investors should monitor for potential impairment if growth slows.

Retained Earnings Deficit Widens

Retained earnings deteriorated from -$421M in 2024Q1 to -$1.0B in 2026Q2, reflecting cumulative net losses, while equity remained flat at $6.4B, per balance sheet data, suggesting offsetting equity injections.

The retained earnings deficit has more than doubled over the period, from -$421M to -$1.0B, consistent with the cumulative net losses reported in the income statement. Despite this, total equity has remained stable at around $6.4B, implying that other equity components, such as additional paid-in capital, have been increased, possibly through equity issuances or conversions. This suggests that the company is relying on external equity to offset losses, which could dilute existing shareholders if not managed carefully.

Liquidity Position Remains Adequate

Current ratio improved to 1.55 in 2026Q2 from 1.70 in 2024Q1, with cash at $367M, as per the balance sheet, indicating a stable but slightly reduced liquidity buffer.

The current ratio has declined from 1.70 to 1.55 over the period, but remains above 1.5, indicating that current assets comfortably cover current liabilities. Cash has fluctuated between $202M and $383M, with 2026Q2 at $367M, providing a modest buffer against short-term shocks. Given the company's positive operating cash flow in most quarters, liquidity appears adequate, though the low cash balance relative to total assets suggests reliance on operating cash flow and credit facilities for working capital needs.

Goodwill Impairment Risk Looms

Goodwill of $4.7B represents 34% of total assets, and with cumulative net losses exceeding $1B, as per balance sheet data, there is elevated risk of future impairment charges.

The substantial goodwill on the balance sheet, combined with persistent net losses, raises the risk of future impairment charges. While goodwill has remained stable, the company's inability to generate consistent profits may indicate that the carrying value of acquired assets is not fully supported by cash flows. If revenue growth decelerates or margins fail to improve, an impairment could significantly reduce equity and total assets, potentially impacting leverage ratios and investor confidence. This is a non-obvious risk that headline numbers may not fully capture.

BLCO — Frequently Asked Questions

Quick answers to the most common questions about buying BLCO stock.

What are the total assets of Bausch + Lomb Corporation (BLCO)?

As of 2025, Bausch + Lomb Corporation (BLCO) had total assets of $14.02B including $2.98B in current assets.

How much debt does Bausch + Lomb Corporation (BLCO) have?

Bausch + Lomb Corporation (BLCO) carries total debt of $5.37B, offset by $383.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Bausch + Lomb Corporation?

Bausch + Lomb Corporation (BLCO) has total shareholders' equity (book value) of $6.45B ($18.43 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Bausch + Lomb Corporation's current ratio and liquidity?

Bausch + Lomb Corporation (BLCO) reported a current ratio of 1.55x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.